Luisa Guidi
0000-0003-3320-7094
5 papers found
Refreshing results…
Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study
Sa1232 Infliximab Three-Dose Induction Regimen in Severe Corticosteroid-Refractory Ulcerative Colitis: Early and Late Outcome and Predictors of Colectomy
FOXP3+T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFαAgents
Missing publications? Search for publications with a matching author name.